Company
Board Member
2018-01-01–2025-02-20
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
The company reported in an 8-K filed February 20, 2025 that Carl Gordon resigned as Board of Directors, effective February 20, 2025.
“On February 20, 2025, Carl Gordon notified Terns Pharmaceuticals, Inc. (the "Company") of his resignation from the Company's Board of Directors (the "Board"), effective as of February 20, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
Board Member
Proxy statement
2018-01-01–2025-02-20
Organization not stated
Board Member
Proxy statement
2018-01-01–2025-02-20
Recorded roles and call appearances connecting this person to public companies.
Company
Board Member
2018-01-01–2025-02-20
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.